Lessons from early large-scale adoption of celecoxib and rofecoxib by Australian general practitioners

Timothy H J Florin
Med J Aust 2004; 180 (6): . || doi: 10.5694/j.1326-5377.2004.tb05938.x
Published online: 15 March 2004

Timothy H J Florin

  • Timothy H J Florin

  • Department of Medicine, University of Queensland, Mater Health Services’ Adult Hospital, South Brisbane, QLD 4101.


Competing interests:

The author is a co-investigator on several clinical trials, including a Pharmacia-sponsored randomised placebo-controlled trial of anti-paratuberculosis treatment for patients with active Crohn’s disease.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.